Value & Access Resources

High Cholesterol Decision-Making Guides for Providers and Patients to help health care providers engage in shared decision-making conversations with patients about treating and preventing cardiovascular disease. The updated guides include sample questions and talking points providers can use to discuss treatment planning with patients, a fillable treatment planning form, and a patient education handout. Created in collaboration with the Family Heart Foundation, National Lipid Association, and American Pharmacists Association Foundation.

The National Forum for Heart Disease & Stroke Prevention and 32 other organizations representing patients, healthcare providers, public health, payers and purchasers called on Congress and the White House to implement policies that will expand access to care options for patients nationwide, especially in underserved or otherwise vulnerable populations. This builds on a Joint Policy Statement issued by members and partners of the National Forum’s Value & Access Initiative, with recommendations that would enable people to obtain more healthcare services from pharmacists, often closer to where people live or work.

ATRIAL FIBRILLATION (AFib): Shared Decision-Making Resource for Patients and Healthcare Professionals In shared decision-making, patients and healthcare professionals work together to make the best possible healthcare decisions. These decisions consider fact-based information about available options, the clinician’s knowledge and experience, and the patient’s values, questions, and preferences.

The Value & Access initiative brings together diverse decision-makers from varied stakeholder groups (patients, providers, payers, purchasers, public health and pharma/biotech) to engage in discussion and solution-oriented activities on value and access issues related to cardiovascular health. This white paper outlines accomplishments to date, and the evolution of the initiative.

A checklist modeling processes for P&T Committees to consider when managing the formulary system in making equitable coverage decisions, focusing on evidence-based processes to select and promote treatments offering the best therapeutic outcomes, while minimizing potential risks and costs to patients.

What  Do Value & Access Really Mean? A Landscape Report on Stakeholder Perspectives– reports on differences in how the “6 Ps”—patients, providers, payers, purchasers, public health, and pharma/biotech—view these issues. It also finds an area of common ground that may enable stakeholders to work together to solve ever-rising healthcare costs and clashes over cost-containment measures. The report documents changes in stakeholders’ views over the last 3 years and a shift from opposition to collaboration on certain issues related to healthcare access and affordability.

The Value & Access initiative brings together diverse decision-makers from varied stakeholder groups (patients, providers, payers, purchasers, public health and pharma/biotech) to engage in discussion and solution-oriented activities on value and access issues related to cardiovascular health. This white paper outlines accomplishments to date, and the evolution of the initiative.

What Do Value and Access Really Mean? (2016)

Reveals how patients, providers, payers, public health, and industry view the value of therapies and what access means to them.